Moreover, CD84 knockdown substantially attenuated TOM20 (mitochondrial marker), MFN1 (mitochondrial fusion marker), and HMGB1 expression levels, which indicated mitochondrial dysfunction upon CD84 deletion in AML (Figure 7B). This evidence concerns the gene TOMM20 and acute myeloid leukemia.